Search

everythinglearnresearchcommunity

for

Search:↓

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

COVID-19 infection may trigger alopecia areata in some patients.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

The study concludes that long COVID recovery involves time, various treatments, and a strong patient-provider relationship.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Healthcare workers with a positive COVID-19 test were more likely to report long-COVID symptoms.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Long-COVID symptoms in children after MIS-C are similar across different COVID-19 variants, with older age being a key factor.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

COVID-19 can increase the risk of hair loss, especially in people over 40.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

COVID-19 may cause hair loss by affecting hair follicles.

COVID-19-related hair loss may be linked to blood flow disorders and inflammation.

COVID-19 vaccination may lower vitamin D levels and cause hair loss.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Healthcare workers with COVID-19 reported more long-term symptoms, and physical activity may help reduce some of these symptoms.

Skin rashes can help diagnose COVID-19 early.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.